Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?

Withdrawn before enrolling · Not applicable · Has a placebo group

Conditions studied: Quality of Life, Pelvic Organ Prolapse, Prolapses, Vaginal Vault

In brief

The primary aim is to evaluate whether standard administration of Dexamethasone at the time of general anesthesia induction at the time of minimally invasive sacrocolpopexy (MISC) would result in improved quality of recovery (QoR).

Key facts

Study ID

NCT03094442

Run by

The Cleveland Clinic

People needed

0

Starts

2016-12-01

Expected to finish

2019-12-01

Last updated by the study team

2020-02-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women over the age of 18
• Women scheduled for minimally invasive sacrocolpopexy with or without concomitant anti-incontinence procedure and with or without concomitant hysterectomy
• American Society of Anesthesiologists (ASA) class 1-2

You may not qualify if…

• Daily use of steroids, antiemetics in the month prior to surgery
• Chronic pain requiring daily opioid treatment
• History of allergy/intolerance to Dexamethasone
• ASA class 3
• Numerical Pain score (NPS) of more than 4 at baseline
• Renal/Liver disease
• Diabetes mellitus
• Pregnancy
• Inability to answer questionnaires
• Any systemic infections
• Immuno compromised status

Where it is running

• Cleveland Clinic Florida — Weston, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.